Drug intelligence / Profile preview

Origio Sequential Media

Development stage
Unknown
Lead developer
CooperSurgical
Administration
In Vitro
01

Overview

Origio Sequential Media is a specialized system of culture media used in assisted reproductive technology (ART) to support the development of human embryos from the zygote stage to the blastocyst stage. Developed by Origio (a CooperSurgical company), the system typically involves two distinct media: Sequential Cleav, which is optimized for the cleavage stage (Day 1-3), and Sequential Blast, which is formulated to support the embryo from Day 3 to Day 5 or 6 (blastocyst stage). This sequential approach is designed to account for the shifting metabolic requirements of the embryo as it progresses through the reproductive tract, transitioning from a pyruvate and lactate-rich environment to one that is glucose-rich. The media are used in clinical IVF procedures to optimize blastulation rates and improve overall pregnancy outcomes.

Brand names
OrigioSequential CleavSequential Blast
Other names
Origio-Vietnam National UniversityOrigio sequential culture mediaOrigio Sequential Series

Beyond the preview

Go deeper on Origio Sequential Media.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Origio Sequential Media.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call